05 June 2024
GlobalData Plc
(AIM: DATA, GlobalData, the Group)
Investment in Healthcare Division by Inflexion
Investment agreement with Inflexion for a minority stake in GlobalData's Healthcare division
Further to the announcement made on 21 December 2023 regarding the proposed investment by Inflexion Private Equity Partners LLP into GlobalData's Healthcare division, the Company is pleased to announce that all the regulatory and other conditions have now been satisfied and that completion of the investment will take place on 28 June 2024. On completion, the Company will receive net cash proceeds of approximately £434 million.
Mike Danson, CEO of GlobalData, commented: "This investment in our Healthcare division represents a compelling crystallisation of the significant value that has been created for our shareholders through the delivery of our growth strategy. We are delighted to be partnering with Inflexion to take our Healthcare division into its next phase of growth.
Our business will continue to evolve rapidly through our 2024-2026 Growth Transformation Plan, as we invest in products and AI and leverage the proceeds from this transaction to accelerate growth investment and targeted M&A across the Group."
ENDS
ENQUIRIES
GlobalData Plc | |
Mike Danson, Chief Executive Officer | 0207 936 6400 |
Graham Lilley, Chief Financial Officer | |
| |
J.P. Morgan Cazenove (Nomad, Joint Broker) | 0203 493 8000 |
Bill Hutchings | |
Mose Adigun | |
Alex Bruce | |
| |
Panmure Gordon (Joint Broker) | 0207 886 2500 |
Rupert Dearden | |
Dougie McLeod | |
| |
Investec Bank plc (Joint Broker) Henry Reast Virginia Bull
| 0207 597 5970 |
FTI Consulting (Financial PR) | 0203 727 1000 |
Edward Bridges | |
Dwight Burden | |
Emma Hall | |
J.P. Morgan Cazenove is acting as Sole Financial Advisor to GlobalData Plc. Reed Smith LLP is acting as legal counsel to GlobalData.
J.P. Morgan Securities plc, which conducts its UK investment banking activities as J.P. Morgan Cazenove ("J.P. Morgan Cazenove"), and which is authorised in the United Kingdom by the Prudential Regulation Authority and regulated in the United Kingdom by the Financial Conduct Authority and the Prudential Regulation Authority, is acting exclusively as sole financial adviser for GlobalData Plc and no one else in connection with the Transaction and shall not be responsible to anyone other than GlobalData Plc for providing the protections afforded to clients of J.P. Morgan Cazenove or its affiliates, nor for providing advice in connection with the Transaction or any other matter referred to herein
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.